These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31979409)

  • 21. DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis.
    Choi HS; Lee K; Kim MK; Lee KM; Shin YC; Cho SG; Ko SG
    Oncotarget; 2016 Apr; 7(16):21775-85. PubMed ID: 26967562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Hai-Rong C; Xiang H; Xiao-Rong Z
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling.
    Hu WH; Wang HY; Kong XP; Xiong QP; Poon KK; Xu L; Duan R; Chan GK; Dong TT; Tsim KW
    FASEB J; 2019 Jan; 33(1):532-544. PubMed ID: 29989844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.
    Choi HS; Kim MK; Lee K; Lee KM; Choi YK; Shin YC; Cho SG; Ko SG
    Oncotarget; 2016 May; 7(22):32969-79. PubMed ID: 27105528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.
    Li M; Wu S; Liu Z; Zhang W; Xu J; Wang Y; Liu J; Zhang D; Tian H; Li Y; Ye W
    Biochem Pharmacol; 2012 May; 83(9):1251-60. PubMed ID: 22305746
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Cho HD; Kim JH; Park JK; Hong SM; Kim DH; Seo KI
    Pharm Biol; 2019 Dec; 57(1):684-693. PubMed ID: 31608754
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo.
    Zhang HZ; Li CY; Wu JQ; Wang RX; Wei P; Liu MH; He MF
    Phytomedicine; 2018 Sep; 48():10-20. PubMed ID: 30195867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
    Ji L; Wu M; Li Z
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model.
    Kowshik J; Giri H; Kishore TK; Kesavan R; Vankudavath RN; Reddy GB; Dixit M; Nagini S
    Anticancer Agents Med Chem; 2014; 14(9):1249-60. PubMed ID: 25060902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects and mechanisms of Xiao-Ai-Ping injection on angiogenesis].
    Wang MJ; Du DY; Fan W; Zhang C; Liu Y; Fan JH; Yuan ST; Lin SS
    Yao Xue Xue Bao; 2016 Feb; 51(2):309-15. PubMed ID: 29856586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
    Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF signaling in cancer treatment.
    Sia D; Alsinet C; Newell P; Villanueva A
    Curr Pharm Des; 2014; 20(17):2834-42. PubMed ID: 23944367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.
    Ma Q; Chen W; Chen W
    Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.